PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- Pack Health
- Study ID
- NCT05956457
- Status
- Recruiting
Conditions
- Multiple Myeloma
- Relapsed Hematologic Malignancy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Digital Health Coaching Program — BEHAVIORALDigital health intervention consisting of weekly calls from a Health Advisor to a participant, accompanied by delivery of evidence-based content across health and wellness domains (e.g. nutrition, exercise, physical, emotional and financial health) up to 4 times weekly via text, email or mobile application.
- Fitbit — DEVICEA wrist-worn activity tracker allowing for the capture of physical activity, including but not limited to step-count and minutes of activity, to be captured daily.
Study Details
This study will evaluate the feasibility of a digital health coaching program for adults with relapsed or refractory multiple myeloma (R/R MM). One hundred adults with R/R MM will be enrolled at The University of Washington. Individuals who agree to take part in the study and sign an informed consent will be enrolled in a 3-month digital health coaching program. The program will provide weekly phone calls plus the delivery of learning materials to text or email. Questionnaires and data from a wrist-worn activity tracker will be collected. Outcomes include treatment and symptom experience, quality of life, financial burden, and how confident people feel to manage their health. Information about your condition and treatment will be collected, along with how often you use services like the emergency room, for care. This data will provide a better understanding of how a person experiences their R/R MM.
Key Dates
- Start date
- Sep 15, 2023
- Status verified
- Apr 2025
- Primary completion
- May 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Single Arm Cohort Receiving Digital Health CoachingAll study participants will be enrolled in a 3-month digital health coaching program. They will also receive a Fitbit device to be worn daily for the capture of physical activity data.
Primary Outcome Measure
Feasibility of the Digital Health Coaching Intervention [ Time Frame: At 3 months following the start of the coaching intervention ]
Central Contacts
- Kelly Brassil, PhD205-721-7542
- Jennifer Loftis, DNP205-721-7542
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Washington | Seattle | Washington | 98195 | Rahul Banerjee, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Seattle, WA
Related Studies
- Collection of Tissue Samples for Cancer ResearchRecruiting · National Cancer Institute (NCI) · Sacramento, California
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPHASE2 · Recruiting · American Society of Clinical Oncology · Birmingham, Alabama
- A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) PatientsPHASE1 · Recruiting · Oncotherapeutics · Alhambra, California
- CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)PHASE1/PHASE2 · Recruiting · Curis, Inc. · Phoenix, Arizona